Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol

• Published in: Gastroenterology (New York, N.Y. 1943) Vol. 151; no. 4; pp. 733 - 746.e12
• Main Authors: Rahman, Khalidur, Desai, Chirayu, Iyer, Smita S., Thorn, Natalie E., Kumar, Pradeep, Liu, Yunshan, Smith, Tekla, Neish, Andrew S., Li, Hongliang, Tan, Shiyun, Wu, Pengbo, Liu, Xiaoxiong, Yu, Yuanjie, Farris, Alton B., Nusrat, Asma, Parkos, Charles A., Anania, Frank A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2016
• Subjects: Animals; Bacterial Translocation; Cell Adhesion Molecules - deficiency; Cholesterol; Claudin-4; Diet, High-Fat - adverse effects; Diet, High-Fat - methods; Dietary Carbohydrates; Disease Models, Animal; Dysbiosis - complications; Dysbiosis - genetics; Fructose; Gastroenterology and Hepatology; Gastrointestinal Microbiome - genetics; Intestinal Mucosa - metabolism; Intestinal Mucosa - microbiology; Liver - pathology; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease - genetics; Non-alcoholic Fatty Liver Disease - microbiology; Non-alcoholic Fatty Liver Disease - pathology; Occludin; Permeability; Receptors, Cell Surface - deficiency; Reverse Transcriptase Polymerase Chain Reaction; AST; NAFLD; IL; rRNA; ALT; NASH; Bacterial Translocation; Claudin-4; LPS; Occludin; FITC; MetS; TJ; αSMA; HSC; JAM-A; TLR; NAFL; CRN; HFCD; PCR; alanine aminotransferase; Clinical Research Network; nonalcoholic steatohepatitis; high-fat, high-fructose, and high-cholesterol diet; ribosomal RNA; hepatic stellate cell; interleukin; fluorescein isothiocyanate; polymerase chain reaction; tight junction; Toll-like receptor; nonalcoholic fatty liver; junctional adhesion molecule A; aspartate aminotransferase; α smooth muscle actin; metabolic syndrome; nonalcoholic fatty liver disease; lipopolysaccharide
• DOI: 10.1053/j.gastro.2016.06.022
• ISSN: 0016-5085; 1528-0012

There is evidence from clinical studies that compromised intestinal epithelial permeability contributes to the development of nonalcoholic steatohepatitis (NASH), but the exact mechanisms are not clear. Mice with disruption of the gene (F11r) encoding junctional adhesion molecule A (JAM-A) have defects in intestinal epithelial permeability. We used these mice to study how disruption of the intestinal epithelial barrier contributes to NASH. Male C57BL/6 (control) or F11r-/- mice were fed a normal diet or a diet high in saturated fat, fructose, and cholesterol (HFCD) for 8 weeks. Liver and intestinal tissues were collected and analyzed by histology, quantitative reverse-transcription polymerase chain reaction, and flow cytometry. Intestinal epithelial permeability was assessed in mice by measuring permeability to fluorescently labeled dextran. The intestinal microbiota were analyzed using 16S ribosomal RNA sequencing. We also analyzed biopsy specimens from proximal colons of 30 patients with nonalcoholic fatty liver disease (NAFLD) and 19 subjects without NAFLD (controls) undergoing surveillance colonoscopy. F11r-/- mice fed a HFCD, but not a normal diet, developed histologic and pathologic features of severe NASH including steatosis, lobular inflammation, hepatocellular ballooning, and fibrosis, whereas control mice fed a HFCD developed only modest steatosis. Interestingly, there were no differences in body weight, ratio of liver weight:body weight, or glucose homeostasis between control and F11r-/- mice fed a HFCD. In these mice, liver injury was associated with significant increases in mucosal inflammation, tight junction disruption, and intestinal epithelial permeability to bacterial endotoxins, compared with control mice or F11r-/- mice fed a normal diet. The HFCD led to a significant increase in inflammatory microbial taxa in F11r-/- mice, compared with control mice. Administration of oral antibiotics or sequestration of bacterial endotoxins with sevelamer hydrochloride reduced mucosal inflammation and restored normal liver histology in F11r-/- mice fed a HFCD. Protein and transcript levels of JAM-A were significantly lower in the intestinal mucosa of patients with NAFLD than without NAFLD; decreased expression of JAM-A correlated with increased mucosal inflammation. Mice with defects in intestinal epithelial permeability develop more severe steatohepatitis after a HFCD than control mice, and colon tissues from patients with NAFLD have lower levels of JAM-A and higher levels of inflammation than subjects without NAFLD. These findings indicate that intestinal epithelial barrier function and microbial dysbiosis contribute to the development of NASH. Restoration of intestinal barrier integrity and manipulation of gut microbiota might be developed as therapeutic strategies for patients with NASH.